Shares fell due to heavy profit-taking after a recent surge, conservative analyst targets, and broader market interest rate anxiety.
read the report →DVA
DaVita Inc.
DaVita Inc. is a leading healthcare provider specializing in kidney care services across the United States and internationally. It provides outpatient dialysis, home-based hemodialysis, peritoneal dialysis, and integrated kidney care management.
Price history
stitched from the price window carried by each report
Every session it moved
newest firstDaVita reported a full-year guidance midpoint that missed consensus estimates alongside sequential declines in revenue per treatment.
read the report →DaVita fell after reaffirming full-year guidance despite Q2 beats, as ACA subsidy expirations caused margin compression.
read the report →Shares fell after Q2 earnings revealed margin compression, lower commercial payer mix from declining ACA enrollment, and flat guidance.
read the report →The stock fell after DaVita merely reaffirmed guidance despite Q2 beats and warned of lower revenue per treatment from payer mix shifts.
read the report →The stock fell as Q2 revenue per treatment dropped from an adverse ACA payer mix shift and full-year EPS guidance was merely reconfirmed.
read the report →